The European CMO Model, Powering Biologics Innovation
News and updates
Uncategorised
From Concept To Commercial Reality: Successful Upscaling Strategies For Viral Vector Manufacturing
Process development, scale-up and challenges of TM adenovirus GMP process in the iCELLis
Myths That Make Early CDMO Engagement Look Like A Risk
De-Risking AAV Production By Working With An End-To-End CDMO
GMP Recombinant Protein Manufacturing: Key Challenges and How to Address Them
Unlocking Flexible AAV Production: 3PBIOVIAN’s In-House Plasmids And Manufacturing Capacity
Vendor To Visionary: Transforming AAV Manufacturing
3PBIOVIAN reinforces its commitment to continuous learning through UPNA micro-credentials
3PBIOVIAN expands its mammalian capacity with a second 2,000 L bioreactor
3PBIOVIAN Joins “A Day with a Biotech Women”
3PBIOVIAN obtains French CIR Certification for 2025–2027